NanoGenerator® Flex-S Plus Platform
Automated High-throughput
Discovery & Screening
for Lipid Nanoparticle Formulation
High throughput 96 samples per hour
Small volume output
The NanoGenerator Flex-S Plus is an automated high-throughput formulation screening platform designed for nanoparticle synthesis, including lipid nanoparticles (LNPs), liposomes, and PLGA particles.
Notably, the rapid adoption of LNP technology has underscored the potential of nanomedicines. Scientific advancements have demonstrated that LNPs serve as highly effective drug delivery systems across various therapeutic applications. High-throughput LNP screening is a valuable method for identifying the optimal LNP formulations from a diverse set of factors.
The NanoGenerator Flex-S Plus streamlines this process, enabling a swift transition from screening nanoformulations to clinical evaluation and, ultimately, commercialization. NanoGenerator generates nanoparticles with better uniformity in size and smaller PDI. It is scalable from 0.1mL/sample screening up to 1L (>20L with custom design) large volume GMP production.
System Benefits
High Throughput & Efficiency
-
Multiple samples (up to 32) per run
-
Runtime <5min for 4 samples, 96 samples per hour
-
Scalable and reproducible to large volume production
Automation
-
Automated workflow
-
Real-time data monitoring & recording
-
Electronic batch records
High Yield
-
Small reagent volume (minimum 100ul) per sample
-
Save up to 80% of RNA/lipid cost
The Flex-S Plus System facilitates the rapid screening of nanoparticle formulations and early-stage mRNA candidates, offering a substantial increase in project efficiency. With a max throughput of 48/96 experiments an hour, the Flex-S Plus greatly streamlines screening processes. It offers comprehensive automation of complex protocols, enabling users to concentrate on other laboratory duties.
The system also permits experimentation with as little as 20 µl of payload reagent (e.g. mRNA) while providing control over collection volumes. This allows users to optimize the use of valuable materials.
Reproducible
Discovery & Screening
PreciGenome's NanoGenerator platform's precise control of parameters ensures consistent critical quality attributes, such as particle size, throughout the entire development and manufacturing process. This guarantees speed, cost-effectiveness, and reliability at every stage.
Multi-sample Formulation Screening Example
32 sample screening (formulation & N:P ratio screening)
Screening factors with the Flex-S Plus include payloads, carrier formulation, total flow rate, flow rate ratio, N:P ratio, Lipid concentration, and payload concentration. Precise control of parameters ensures consistent CQAs, guaranteeing speed, cost-effectiveness, and reliability at every stage of the experiment.
Path from Discovery to Commercialization
NanoGenerator system offers controllable and reproducible mixing conditions, ensuring the accurate synthesis of LNPs through its scalable architecture found in the entire NanoGenerator product line. This architecture facilitates the seamless transfer of crucial process parameters, guaranteeing consistent critical quality attributes (CQAs) as one transitions from discovery and screening, process development to GMP production and commercial manufacturing for a wide range of applications, such as mRNA LNP vaccine development.
Transferable results from early discovery and screening (Flex-S/Flex-S Plus, 0.1mL) to pre-clinical development (Pro, 200mL), then commercial production (Max: 1L, MAX 40L/H: >20L)
Workflow
Screening factors with the Flex-S Plus include payloads, carrier formulation, total flow rate, flow rate ratio, N:P ratio, and LNP concentration. Precise control of parameters ensures consistent CQAs, guaranteeing speed, cost-effectiveness, and reliability at every stage of the experiment.